Trials / Sponsors / LB Pharmaceuticals Inc.
LB Pharmaceuticals Inc.
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | 52-week Open Label Safety-Tolerability Study Schizophrenia | Phase 3 | 2026-04-01 |
| Recruiting | Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia Schizophrenia | Phase 3 | 2026-03-25 |
| Recruiting | Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. Bipolar I Disorder | Phase 2 | 2026-01-23 |
| Completed | Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Sc Schizophrenia | Phase 2 | 2023-11-29 |
| Completed | Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers Schizophrenia | Phase 1 | 2021-01-05 |
| Completed | Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults Schizophrenia | Phase 1 | 2020-01-22 |